Confirmatory Study of BK1310 in Healthy Infants

Clinical trial NCT03891758 · COMPLETED

Trial details

NCT number: NCT03891758
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Diphtheria Pertussis Poliomyelitis Bacterial Meningitis

Start date: 2019-04-01
Primary completion: 2019-09-18
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.